{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-024544","form_type":"8-K","ticker":"SNDX","cik":"0001395937","company_name":"Syndax Pharmaceuticals Inc","filed_at":"2023-05-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.688699+00:00","generated_at":"2026-06-14T12:42:59.023664+00:00","sec_items":["1.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Syndax enters new $200M at-the-market equity facility with TD Cowen, replacing prior $75M program","bullets":["Prior $75M ATM facility terminated on March 26, 2023; gross proceeds of $25M raised before termination.","New $200M ATM agreement signed May 26, 2023; shares sold at market prices through TD Cowen as agent.","Compensation to TD Cowen up to 3.0% of gross sales price; indemnification provisions included.","Offering may be suspended by either party; termination upon full sale or agreement end.","Cooley LLP legal opinion on Placement Shares filed as Exhibit 5.1 to the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-024544","json":"https://secwatch.observer/filing/0000950170-23-024544.json","markdown":"https://secwatch.observer/filing/0000950170-23-024544.md","text":"https://secwatch.observer/filing/0000950170-23-024544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/0000950170-23-024544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/sndx-20230526.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T12:42:59.023664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4a7386e55df9cdfe48c72de338493e7d22d392ad","claim":"Syndax Pharmaceuticals Inc terminated Prior Sales Agreement with Cowen and Company, LLC (effective 2023-03-26).","evidence_excerpt":"On March 26, 2023, Syndax delivered written notice to TD Cowen to terminate the Prior Sales Agreement pursuant to Section 11(b) thereof.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1395937/000095017023024544/0000950170-23-024544-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"termination"},{"label":"Agreement","value":"atm program"},{"label":"Counterparty","value":"Cowen and Company, LLC"},{"label":"Effective","value":"2023-03-26"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}